Benefits of aldosterone receptor antagonism in chronic kidney disease: the BARACK-D RCT.
Hobbs FDR. et al, (2025), Health Technol Assess, 29, 1 - 130
Supporting people with type 2 diabetes in effective use of their medicine through mobile health technology integrated with clinical care (SuMMiT-D pilot): results of a feasibility randomised trial
Farmer AJ. et al, (2024), Pilot and Feasibility Studies, 10
Supporting People With Type 2 Diabetes in the Effective Use of Their Medicine Through Mobile Health Technology Integrated With Clinical Care to Reduce Cardiovascular Risk: Protocol for an Effectiveness and Cost-effectiveness Randomized Controlled Trial
Farmer A. et al, (2022), JMIR Research Protocols, 11
Supporting people with type 2 diabetes in effective use of their medicine through mobile health technology integrated with clinical care to reduce cardiovascular risk (SuMMiT-D): an effectiveness and cost-effectiveness randomised control trial protocol
FARMER A. et al, (2021), JMIR Research Protocols
Frequency of Renal Monitoring - Creatinine and Cystatin C (FORM-2C): An observational cohort study of patients with reduced eGFR in primary care
Fleming S. et al, (2021), British Journal of General Practice, 71, E677 - E684
Self-Management Support Using a Digital Health System Compared With Usual Care for Chronic Obstructive Pulmonary Disease: Randomized Controlled Trial
Farmer A. et al, (2017), Journal of Medical Internet Research, 19
The role of Der p 1 specific T cells in atopic eczema
Chan HW. et al, (2013), AUSTRALASIAN JOURNAL OF DERMATOLOGY, 54, 13 - 14
Human antimicrobial peptides LL-37 and human β-defensin-2 reduce viral replication in keratinocytes infected with varicella zoster virus
Crack LR. et al, (2012), Clinical and Experimental Dermatology, 37, 534 - 543
Human antimicrobial peptides LL-37 and human β-defensin-2 reduce viral replication in keratinocytes infected with varicella zoster virus
Crack LR. et al, (2012), Clinical and Experimental Dermatology
Antigen dose and keratinocyte antigen presentation are specific determinants of T cell function in atopic eczema
Chan HW. et al, (2011), AUSTRALASIAN JOURNAL OF DERMATOLOGY, 52, 19 - 20
Central role of JC virus-specific CD4+ lymphocytes in progressive multi-focal leucoencephalopathy-immune reconstitution inflammatory syndrome
Aly L. et al, (2011), Brain, 134, 2687 - 2702
Frequencies of circulating allergen-specific T cells temporally associate with longitudinal changes in severity of cutaneous atopic disease
McPherson T. et al, (2010), Clinical and Experimental Dermatology, 35, 786 - 788
Filaggrin null mutations associate with increased frequencies of allergen-specific CD4+ T-helper 2 cells in patients with atopic eczema.
McPherson T. et al, (2010), Br J Dermatol, 163, 544 - 549
Natural Killer Cells During Primary Varicella Zoster Virus Infection.
Malavige GN. et al, (2010), J Infect
IE63-specific T-cell responses associate with control of subclinical varicella zoster virus reactivation in individuals with malignancies
Malavige GN. et al, (2010), British Journal of Cancer, 102, 727 - 730
Tracking epitope-specific antiviral CD4+ T cell responses to a live attenuated vaccine reveals ongoing functional responses
Jones L. et al, (2009), Vaccine, 27, 7398 - 7401